泌尿病学的转化里程碑:跨癌症类型的分子诊断
Andres Matoso1,2,3, Andres M Acosta4
1Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
The journal of pathology. Clinical research
|September 2, 2025
概括
精确瘤学在泌尿癌的分子诊断方面取得了进展. 最近的研究强调了癌症干细胞,上皮转化为介质细胞 (EMT) 调节剂和DNA甲基化标记物,以改善风险分层和向治疗.
科学领域:
- 病理学
- 癌症学
- 分子诊断
背景情况:
- "病理学杂志:临床研究"是翻译性癌症研究的主要来源.
- 精确瘤学在癌症研究和治疗中越来越重要.
研究的目的:
- 突出最近在尿道癌分子诊断方面的贡献.
- 展示精确瘤学的进展及其临床应用.
主要方法:
- 对癌症干细胞,表皮细胞转化为介质细胞 (EMT),同源重组修复 (HRR) 基因测试,TP53变异,转录基因分析,DNA甲基化标志物和数字空间分析的研究的综述.
- 分析各种泌尿和儿科癌症的预后模型和分子亚型.
主要成果:
- 癌症干细胞和瘤微环境影响细胞癌的耐药性.
- 在前列腺癌中,EMT调节器 (Twist,Slug,Snail) 是不良的预后标志物.
- HRR基因测试支持多 (ADP- 核糖) 聚合酶抑制剂治疗.
- 在威尔姆斯瘤中,TP53的改变具有更广泛的预后意义.
- 转录基因分析有助于治疗膀癌.
- 基因组甲基化标记可以提高清细胞癌的预后准确性.
- 数字空间分析揭示了尿癌的免疫抑制微环境.
结论:
- 综合分子诊断正在改变泌尿癌的个性化治疗方法.
- 病理学研究的进步对于精确瘤学至关重要.
- 分子标记增强风险分层和治疗策略,以改善患者的治疗结果.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


